These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9412543)

  • 1. Effects of beta blockers on symptoms and functional capacity in heart failure.
    Fowler MB
    Am J Cardiol; 1997 Dec; 80(11A):55L-58L. PubMed ID: 9412543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life?
    Fowler MB
    Eur Heart J; 1998 Dec; 19 Suppl P():P17-25. PubMed ID: 9886708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cold exposure on submaximal exercise performance and adrenergic activation in patients with congestive heart failure and the effects of beta-adrenergic blockade (carvedilol or metoprolol).
    Blanchet M; Ducharme A; Racine N; Rouleau JL; Tardif JC; Juneau M; Marquis J; Larivée L; Nigam A; Fortier A; White M
    Am J Cardiol; 2003 Sep; 92(5):548-53. PubMed ID: 12943875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carvedilol versus other beta-blockers in heart failure.
    Doggrell SA
    Expert Opin Investig Drugs; 2001 May; 10(5):971-80. PubMed ID: 11322870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary on the Carvedilol or Metoprolol European Trial (COMET).
    Poole-Wilson PA
    Am J Cardiol; 2004 May; 93(9A):40B-2B. PubMed ID: 15144936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blockers in heart failure. The 'new wave' of clinical trials.
    Krum H
    Drugs; 1999 Aug; 58(2):203-10. PubMed ID: 10473016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group.
    Cohn JN; Fowler MB; Bristow MR; Colucci WS; Gilbert EM; Kinhal V; Krueger SK; Lejemtel T; Narahara KA; Packer M; Young ST; Holcslaw TL; Lukas MA
    J Card Fail; 1997 Sep; 3(3):173-9. PubMed ID: 9330125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.
    Kveiborg B; Major-Petersen A; Christiansen B; Torp-Pedersen C
    Vasc Health Risk Manag; 2007; 3(1):31-7. PubMed ID: 17583173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of beta blockers in heart failure.
    Talbert RL
    Heart Fail Rev; 2004 Apr; 9(2):131-7. PubMed ID: 15516861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
    Torp-Pedersen C; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lutiger B; Metra M; Remme WJ; Scherhag A; Skene A;
    Am Heart J; 2005 Feb; 149(2):370-6. PubMed ID: 15846279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of beta-blockers in congestive heart failure.
    Sallach JA; Goldstein S
    Ann Med; 2003; 35(4):259-66. PubMed ID: 12846268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
    Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
    Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics of beta-blockers in heart failure: lessons from the carvedilol or metoprolol European trial.
    Bauman JL; Talbert RL
    J Cardiovasc Pharmacol Ther; 2004 Jun; 9(2):117-28. PubMed ID: 15309248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.
    Lancet; 1997 Feb; 349(9049):375-80. PubMed ID: 9033462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-blockers for chronic heart failure: surviving longer but feeling better?
    Bolger AP; Al-Nasser F
    Int J Cardiol; 2003 Nov; 92(1):1-8. PubMed ID: 14602210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Landmark studies: the Australia/New Zealand Heart Failure Collaborative Group (ANZ) Trial and the US Carvedilol Trials Program.
    Gilbert EM
    Am J Cardiol; 2004 May; 93(9A):30B-4B. PubMed ID: 15144934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beta-blocking drugs indicated in patients with heart failure].
    Voors AA; van Gilst WH; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2457-9. PubMed ID: 14708208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET.
    Poole-Wilson PA; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Metra M; J Remme W; Swedberg K; Torp-Pedersen C
    Eur J Heart Fail; 2002 Jun; 4(3):321-9. PubMed ID: 12034158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.